![Cancers | Free Full-Text | CD33 Expression and Gentuzumab Ozogamicin in Acute Myeloid Leukemia: Two Sides of the Same Coin Cancers | Free Full-Text | CD33 Expression and Gentuzumab Ozogamicin in Acute Myeloid Leukemia: Two Sides of the Same Coin](https://www.mdpi.com/cancers/cancers-13-03214/article_deploy/html/images/cancers-13-03214-g001.png)
Cancers | Free Full-Text | CD33 Expression and Gentuzumab Ozogamicin in Acute Myeloid Leukemia: Two Sides of the Same Coin
![Targeting CD33 in Chemoresistant AML Patient-Derived Xenografts by CAR-CIK Cells Modified with an Improved SB Transposon System - ScienceDirect Targeting CD33 in Chemoresistant AML Patient-Derived Xenografts by CAR-CIK Cells Modified with an Improved SB Transposon System - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S1525001620302859-fx1.jpg)
Targeting CD33 in Chemoresistant AML Patient-Derived Xenografts by CAR-CIK Cells Modified with an Improved SB Transposon System - ScienceDirect
![The CD33 short isoform is a gain-of-function variant that enhances Aβ1–42 phagocytosis in microglia | Molecular Neurodegeneration | Full Text The CD33 short isoform is a gain-of-function variant that enhances Aβ1–42 phagocytosis in microglia | Molecular Neurodegeneration | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs13024-021-00443-6/MediaObjects/13024_2021_443_Fig7_HTML.png)
The CD33 short isoform is a gain-of-function variant that enhances Aβ1–42 phagocytosis in microglia | Molecular Neurodegeneration | Full Text
![CD45+CD33lowCD11bdim myeloid-derived suppressor cells suppress CD8+ T cell activity via the IL-6/IL-8-arginase I axis in human gastric cancer | Cell Death & Disease CD45+CD33lowCD11bdim myeloid-derived suppressor cells suppress CD8+ T cell activity via the IL-6/IL-8-arginase I axis in human gastric cancer | Cell Death & Disease](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41419-018-0803-7/MediaObjects/41419_2018_803_Fig1_HTML.jpg)
CD45+CD33lowCD11bdim myeloid-derived suppressor cells suppress CD8+ T cell activity via the IL-6/IL-8-arginase I axis in human gastric cancer | Cell Death & Disease
![CD33 Alzheimer's Risk-Altering Polymorphism, CD33 Expression, and Exon 2 Splicing | Journal of Neuroscience CD33 Alzheimer's Risk-Altering Polymorphism, CD33 Expression, and Exon 2 Splicing | Journal of Neuroscience](https://www.jneurosci.org/content/jneuro/33/33/13320/F2.large.jpg)
CD33 Alzheimer's Risk-Altering Polymorphism, CD33 Expression, and Exon 2 Splicing | Journal of Neuroscience
![CD123/CD33 dual-antibody modified liposomes effectively target acute myeloid leukemia cells and reduce antigen-negative escape - ScienceDirect CD123/CD33 dual-antibody modified liposomes effectively target acute myeloid leukemia cells and reduce antigen-negative escape - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0378517319305629-ga1.jpg)
CD123/CD33 dual-antibody modified liposomes effectively target acute myeloid leukemia cells and reduce antigen-negative escape - ScienceDirect
![Immunodepletion of MDSC by AMV564, a novel bivalent, bispecific CD33/CD3 T cell engager, ex vivo in MDS and melanoma: Molecular Therapy Immunodepletion of MDSC by AMV564, a novel bivalent, bispecific CD33/CD3 T cell engager, ex vivo in MDS and melanoma: Molecular Therapy](https://www.cell.com/cms/attachment/d6e5115d-6092-48ad-ab06-263394feb87d/fx1_lrg.jpg)
Immunodepletion of MDSC by AMV564, a novel bivalent, bispecific CD33/CD3 T cell engager, ex vivo in MDS and melanoma: Molecular Therapy
![CD33M inhibits microglial phagocytosis, migration and proliferation, but the Alzheimer's disease‐protective variant CD33m stimulates phagocytosis and proliferation, and inhibits adhesion - Butler - 2021 - Journal of Neurochemistry - Wiley Online Library CD33M inhibits microglial phagocytosis, migration and proliferation, but the Alzheimer's disease‐protective variant CD33m stimulates phagocytosis and proliferation, and inhibits adhesion - Butler - 2021 - Journal of Neurochemistry - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/e6aaf69f-59c3-4abb-8754-01a81566d589/jnc15349-fig-0008-m.jpg)
CD33M inhibits microglial phagocytosis, migration and proliferation, but the Alzheimer's disease‐protective variant CD33m stimulates phagocytosis and proliferation, and inhibits adhesion - Butler - 2021 - Journal of Neurochemistry - Wiley Online Library
![Frontiers | CD33 Expression on Peripheral Blood Monocytes Predicts Efficacy of Anti-PD-1 Immunotherapy Against Non-Small Cell Lung Cancer Frontiers | CD33 Expression on Peripheral Blood Monocytes Predicts Efficacy of Anti-PD-1 Immunotherapy Against Non-Small Cell Lung Cancer](https://www.frontiersin.org/files/Articles/842653/fimmu-13-842653-HTML/image_m/fimmu-13-842653-g003.jpg)
Frontiers | CD33 Expression on Peripheral Blood Monocytes Predicts Efficacy of Anti-PD-1 Immunotherapy Against Non-Small Cell Lung Cancer
![Cancers | Free Full-Text | Challenges and Advances in Chimeric Antigen Receptor Therapy for Acute Myeloid Leukemia Cancers | Free Full-Text | Challenges and Advances in Chimeric Antigen Receptor Therapy for Acute Myeloid Leukemia](https://pub.mdpi-res.com/cancers/cancers-14-00497/article_deploy/html/images/cancers-14-00497-g001.png?1642599043)
Cancers | Free Full-Text | Challenges and Advances in Chimeric Antigen Receptor Therapy for Acute Myeloid Leukemia
![Hypoxia/ischemia impairs CD33 (Siglec-3)/TREM2 signaling: Potential role in Alzheimer's pathogenesis - ScienceDirect Hypoxia/ischemia impairs CD33 (Siglec-3)/TREM2 signaling: Potential role in Alzheimer's pathogenesis - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0197018621002321-gr1.jpg)
Hypoxia/ischemia impairs CD33 (Siglec-3)/TREM2 signaling: Potential role in Alzheimer's pathogenesis - ScienceDirect
![Reporter cell assay for human CD33 validated by specific antibodies and human iPSC-derived microglia | Scientific Reports Reporter cell assay for human CD33 validated by specific antibodies and human iPSC-derived microglia | Scientific Reports](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41598-021-92434-2/MediaObjects/41598_2021_92434_Fig2_HTML.png)
Reporter cell assay for human CD33 validated by specific antibodies and human iPSC-derived microglia | Scientific Reports
![Frontiers | CD33 Delineates Two Functionally Distinct NK Cell Populations Divergent in Cytokine Production and Antibody-Mediated Cellular Cytotoxicity Frontiers | CD33 Delineates Two Functionally Distinct NK Cell Populations Divergent in Cytokine Production and Antibody-Mediated Cellular Cytotoxicity](https://www.frontiersin.org/files/Articles/798087/fimmu-12-798087-HTML-r1/image_m/fimmu-12-798087-g001.jpg)
Frontiers | CD33 Delineates Two Functionally Distinct NK Cell Populations Divergent in Cytokine Production and Antibody-Mediated Cellular Cytotoxicity
![T cell engaging bispecific antibodies targeting CD33 IgV and IgC domains for the treatment of acute myeloid leukemia | Journal for ImmunoTherapy of Cancer T cell engaging bispecific antibodies targeting CD33 IgV and IgC domains for the treatment of acute myeloid leukemia | Journal for ImmunoTherapy of Cancer](https://jitc.bmj.com/content/jitc/9/5/e002509/F1.large.jpg)
T cell engaging bispecific antibodies targeting CD33 IgV and IgC domains for the treatment of acute myeloid leukemia | Journal for ImmunoTherapy of Cancer
![CD33 expression on natural killer cells is a potential confounder for residual disease detection in acute myeloid leukemia by flow cytometry - Eckel - 2020 - Cytometry Part B: Clinical Cytometry - Wiley Online Library CD33 expression on natural killer cells is a potential confounder for residual disease detection in acute myeloid leukemia by flow cytometry - Eckel - 2020 - Cytometry Part B: Clinical Cytometry - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/101abd0b-f86f-4b2f-ac09-83860ae593b8/cytob21846-fig-0001-m.jpg)